GT Biopharma Inc (GTBP)
3.30
+0.10
(+3.29%)
USD |
NASDAQ |
May 03, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2014 | -6.06% |
| September 30, 2014 | -66.67% |
| June 30, 2014 | 32.00% |
| March 31, 2014 | |
| December 31, 2013 | 46.34% |
| September 30, 2013 | 32.79% |
| June 30, 2013 | 78.57% |
| March 31, 2013 | 21.59% |
| December 31, 2012 | 72.15% |
| September 30, 2012 | 73.33% |
| June 30, 2012 | |
| March 31, 2012 | 0.00% |
| December 31, 2011 | |
| September 30, 2011 | -300.0% |
| June 30, 2011 | -1.40K% |
| March 31, 2011 | -25.00% |
| December 31, 2010 | -490.9% |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | -100.0% |
| September 30, 2009 | |
| June 30, 2009 | 42.86% |
| March 31, 2009 | |
| December 31, 2008 | 38.41% |
| Date | Value |
|---|---|
| September 30, 2008 | -24.44% |
| June 30, 2008 | 35.90% |
| March 31, 2008 | 39.16% |
| December 31, 2007 | 23.11% |
| September 30, 2007 | 51.28% |
| June 30, 2007 | 57.36% |
| March 31, 2007 | 47.59% |
| December 31, 2006 | 49.10% |
| September 30, 2006 | 52.05% |
| June 30, 2006 | 38.57% |
| March 31, 2006 | 46.07% |
| December 31, 2005 | 43.65% |
| September 30, 2005 | 37.41% |
| June 30, 2005 | 48.29% |
| March 31, 2005 | 54.68% |
| December 31, 2004 | 7.07% |
| September 30, 2004 | 70.44% |
| June 30, 2004 | 45.03% |
| March 31, 2004 | 44.44% |
| December 31, 2003 | 41.96% |
| September 30, 2003 | 54.46% |
| June 30, 2003 | 30.71% |
| March 31, 2003 | 59.93% |
| December 31, 2002 | 52.84% |
| September 30, 2002 | 43.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cutera Inc | 12.60% |
| Outlook Therapeutics Inc | -- |
| 180 Life Sciences Corp | -- |
| Journey Medical Corp | 60.58% |
| NovaBay Pharmaceuticals Inc | 48.70% |